TCF4 and colorectal carcinoma: A study reported by Meyer and colleagues using chromatin immunoprecipitation assays followed by high-throughput DNA sequencing (ChIP-Seq) in the CRC cell line LS180 concluded that β-catenin/TCF4 and VDR/RXR heterodimers colocalize at 74 sites near a limited set of genes that included c-MYC and c-FOS oncogenes [71].